Table 4.
Sol-gel silica-based oral delivery NPs (adapted and reproduced with permission from [102]).
Oral Delivery System | Silica Source | Payload | Coating | Encapsulation Method | Release Mechanism | In Vitro/In Vivo/Ex Vivo | Ref. |
---|---|---|---|---|---|---|---|
Non-porous SiO2 NPs | |||||||
Stober NPs | TEOS | Insulin | PEG 6000PEG 20,000 | Physisorption of insulin to as-synthesized SiO2 NPs–subsequent PEG coating | Passive diffusion | Ex vivo permeation studies with everted rat intestine | [103] |
Stober NPs | TEOS | Insulin | Chitosan | Physisorption of insulin in chitosan suspension to as-synthesized SiO2 NPs | Passive diffusion | In vitro studies of NPs interactions with porcine mucin | [104] |
Mesoporous SiO2 NPs | |||||||
MCM-48 | Luox AS40 | Ibuprofen | Physisorption by immersion | Passive diffusion | In vitro drug release in a simulated body fluid (pH 7.4–7.7) | [105] | |
Ia3d MSM | TEOS/MPTS | Erythromycin | |||||
SBA-15 SiO2 | nf | Itraconazole | Physisorption by immersion | Passive diffusion | In vitro drug release in a simulated gastric fluid (pH 1.2) | [106] | |
SBA-15 and MCM-41 functionalized with –NH2 groups | nf | Bisphosphonates | Electrostatic interaction between drug’s phosphate group and silica’s amnine group at pH 4.8 | Passive diffusion t pH 7.4 | In vitro drug release in phosphate buffer (pH 7.4) | [107] | |
MCM41 microparticles | TEOS/tri-ethanolamine | Folic acid | Impregnation | pH triggered | Yoghurt in vitro drug release in a simulated GIT fluid (pH 2, 4, 7.5) | [108] | |
MCM41 NPs | nf | Rhodamine B | a-CD, adamantly ester | Physisorption | Porcine liver esterase triggered | In vitro hydrolysis in HEPES buffer pH 7.5 | [109] |
MCM48 | TEOS/APTES | Silfalazine | Succinylated soy protein isolate | Physisorption and coating | pH/enzyme triggered | In vitro drug release in simulated GIT fluid at pH 1.2, 5, 7.4 | [110] |
Hybrid silica microparticles | |||||||
Core-shell (mesostructured SiO2) | TMOS | Curcumin | 1. Encapsulation of curcumin in SLN by emulsification/sonication 2. sol-gel |
Passive diffusion | In vitro drug release in a simulated GIT fluid (pH 1.2–7.4) | [111] | |
Core-shell alginate SiO2 | TMOS/APTMS | LGG | 1. Preparation of LGG/alginate microgels by electrospraying 2. mineralization |
Erosion of silica shell | In vitro drug release in a simulated GIT fluid (pH 1.2–7.4) | [111] | |
Diatoms silica microparticles | |||||||
Diatom silica | fossile | Indomethacin/gentamicin | Physisorption | Passive diffusion | In vitro drug release in a simulated intestinal fluid (pH 7.2) | [112] | |
Diatom silica | fossile | Mesalamine/prednisone | Physisorption | Passive diffusion | In vitro drug release in a simulated GIT fluid (pH 1.2–7.4) | [97] |